These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 32833589)

  • 1. Hospital care for opioid use disorder in pregnancy: Challenges and opportunities identified from a Minnesota survey.
    Dopp A; Zabel Thornton M; Kozhimannil K; Jones CW; Greenfield B
    Womens Health (Lond); 2020; 16():1745506520952006. PubMed ID: 32833589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Maternal Opioid Use Disorder and Neonatal Abstinence Syndrome Among Rural US Residents, 2007-2014.
    Kozhimannil KB; Chantarat T; Ecklund AM; Henning-Smith C; Jones C
    J Rural Health; 2019 Jan; 35(1):122-132. PubMed ID: 30370563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rural Postpartum Women With Substance Use Disorders.
    Kramlich D; Kronk R; Marcellus L; Colbert A; Jakub K
    Qual Health Res; 2018 Jul; 28(9):1449-1461. PubMed ID: 29651928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Among County-Level Economic Factors, Clinician Supply, Metropolitan or Rural Location, and Neonatal Abstinence Syndrome.
    Patrick SW; Faherty LJ; Dick AW; Scott TA; Dudley J; Stein BD
    JAMA; 2019 Jan; 321(4):385-393. PubMed ID: 30694320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rural and Urban Differences in Neonatal Abstinence Syndrome and Maternal Opioid Use, 2004 to 2013.
    Villapiano NL; Winkelman TN; Kozhimannil KB; Davis MM; Patrick SW
    JAMA Pediatr; 2017 Feb; 171(2):194-196. PubMed ID: 27942711
    [No Abstract]   [Full Text] [Related]  

  • 6. Conceptualizing Neonatal Abstinence Syndrome as a Cascade of Care: A Qualitative Study With Healthcare Providers in Ohio.
    Syvertsen JL; Toneff H; Madden DR; Clapp JD
    Adv Neonatal Care; 2018 Dec; 18(6):488-499. PubMed ID: 30234507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends of Neonatal Abstinence Syndrome Epidemic and Maternal Risk Factors in Florida.
    Wang X; Zhu Y; Dave CV; Alrwisan AA; Voils SA; Winterstein AG
    Pharmacotherapy; 2017 Jul; 37(7):806-813. PubMed ID: 28500694
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neonatal Abstinence Syndrome (NAS) in Southwestern Border States: Examining Trends, Population Correlates, and Implications for Policy.
    Hussaini KS; Garcia Saavedra LF
    Matern Child Health J; 2018 Sep; 22(9):1352-1359. PubMed ID: 29572587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. State Strategies to Address Opioid Use Disorder Among Pregnant and Postpartum Women and Infants Prenatally Exposed to Substances, Including Infants with Neonatal Abstinence Syndrome.
    Kroelinger CD; Rice ME; Cox S; Hickner HR; Weber MK; Romero L; Ko JY; Addison D; Mueller T; Shapiro-Mendoza C; Fehrenbach SN; Honein MA; Barfield WD
    MMWR Morb Mortal Wkly Rep; 2019 Sep; 68(36):777-783. PubMed ID: 31513558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal Abstinence Syndrome In The United States, 2004-16.
    Leech AA; Cooper WO; McNeer E; Scott TA; Patrick SW
    Health Aff (Millwood); 2020 May; 39(5):764-767. PubMed ID: 32364857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementing a Learning Collaborative Framework for States Working to Improve Outcomes for Vulnerable Populations: The Opioid Use Disorder, Maternal Outcomes, and Neonatal Abstinence Syndrome Initiative Learning Community.
    Kroelinger CD; Addison D; Rodriguez M; Rice ME; Frey MT; Hickner HR; Weber MK; Mueller T; Velonis A; Uesugi K; Romero L; Akbarali S; Foster N; Ko JY; Pliska E; Mackie C; Cox S; Fehrenbach SN; Barfield WD
    J Womens Health (Larchmt); 2020 Apr; 29(4):475-486. PubMed ID: 32176568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breastfeeding in Women on Opioid Maintenance Therapy: A Review of Policy and Practice.
    Clark RRS
    J Midwifery Womens Health; 2019 Sep; 64(5):545-558. PubMed ID: 31294522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rural and Appalachian Disparities in Neonatal Abstinence Syndrome Incidence and Access to Opioid Abuse Treatment.
    Brown JD; Goodin AJ; Talbert JC
    J Rural Health; 2018 Dec; 34(1):6-13. PubMed ID: 28685864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of Tennessee's Opioid Legislation for Neonatal Abstinence Syndrome.
    Shearer JN; Erwin PC; Davis SK; Anderson JG; Lindley LC
    Policy Polit Nurs Pract; 2019 Aug; 20(3):153-162. PubMed ID: 31390304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The interaction of neonatal abstinence syndrome and opioid use disorder treatment availability for women insured by medicaid.
    Reising VA; Horne A; Bennett AC
    Public Health Nurs; 2021 Jan; 38(1):98-105. PubMed ID: 33025600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Infants Born to Opioid-Dependent Women in Ontario, 2002-2014.
    Brogly SB; Turner S; Lajkosz K; Davies G; Newman A; Johnson A; Dow K
    J Obstet Gynaecol Can; 2017 Mar; 39(3):157-165. PubMed ID: 28343557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Policy perceptions of US state public health and child and family services regarding maternal opioid use and neonatal exposure.
    Scott LF; Stone C; Duwve J
    Arch Psychiatr Nurs; 2019 Oct; 33(5):22-30. PubMed ID: 31711589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The opioid epidemic and neonatal abstinence syndrome in the USA: a review of the continuum of care.
    Pryor JR; Maalouf FI; Krans EE; Schumacher RE; Cooper WO; Patrick SW
    Arch Dis Child Fetal Neonatal Ed; 2017 Mar; 102(2):F183-F187. PubMed ID: 28073819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urban-Rural Disparities in Opioid Use Disorder Prevention and Response Activities: A Cross-Sectional Analysis.
    Swann WL; Kim S; Kim SY; Schreiber TL
    J Rural Health; 2021 Jan; 37(1):16-22. PubMed ID: 32639664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pregnant women with opioid use disorder and their infants in three state Medicaid programs in 2013-2016.
    Clemans-Cope L; Lynch V; Howell E; Hill I; Holla N; Morgan J; Johnson P; Cross-Barnet C; Thompson JA
    Drug Alcohol Depend; 2019 Feb; 195():156-163. PubMed ID: 30677745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.